Preoperative Analgesia: The Effectiveness of the PENG Block in Patients With Hip Fractures

NCT ID: NCT07003633

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim is to provide effective preoperative analgesia in patients undergoing surgical procedures due to hip fractures by administering a pericapsular nerve group (PENG) block under ultrasound guidance. This approach seeks to increase patient satisfaction, reduce analgesic requirements, enable earlier discharge, and decrease morbidity and mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fracture Surgeries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
The patients will be randomized to their rescpective groups with closed envelope method.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group PENG

Group PENG will involve the patients who will be performed PENG block 24 hours before surgery.

Group Type EXPERIMENTAL

PENG block with 0.25% bupivacaine guided by ultrasound.

Intervention Type PROCEDURE

PENG (Pericapsular nerve block) is a peripheral nerve block which is performed for patients with hip fractures aimed to prevent preoperative and postoperative pain. It is performed under sterile conditions under ultrasound guideance.

Group Control

Group Control will involve the patients who will not be performed PENG block preoperatively.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PENG block with 0.25% bupivacaine guided by ultrasound.

PENG (Pericapsular nerve block) is a peripheral nerve block which is performed for patients with hip fractures aimed to prevent preoperative and postoperative pain. It is performed under sterile conditions under ultrasound guideance.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing hip farcture surgery

Exclusion Criteria

* Chronic analgesics consumption
* Patients contraindicated for neuraxial anesthesia
* Alcohol and drug addiction
* Allergies to local anesthetics and opioids
* Patients who refuses to participate in the study
Minimum Eligible Age

45 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sakarya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alim Miniksar, MD

Anesthesiology and Reanimation Resident, M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sakarya Universtiy Training and Research Hospital

Sakarya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alim Miniksar, M.D.

Role: CONTACT

+905069499002

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alim Miniksar, M.D.

Role: primary

+905069499002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-43012747-050.04-463726-205

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

'The Effect of Adding LFCN Block to PENG
NCT06226675 ACTIVE_NOT_RECRUITING NA